|
Originally published In Press as doi:10.1074/jbc.M202683200 on May 1, 2002
J. Biol. Chem., Vol. 277, Issue 28, 25070-25081, July 12, 2002
Structures of Lipopolysaccharides from Klebsiella
pneumoniae
ELUCIDATION OF THE STRUCTURE OF THE LINKAGE REGION
BETWEEN CORE AND POLYSACCHARIDE O CHAIN AND IDENTIFICATION
OF THE RESIDUES AT THE NON-REDUCING TERMINI OF THE O
CHAINS*
Evgeny
Vinogradov §,
Emilisa
Frirdich¶ ,
Leann L.
MacLean ,
Malcolm B.
Perry ,
Bent O.
Petersen**,
Jens
Ø.
Duus**, and
Chris
Whitfield¶
From the Institute for Biological Sciences,
National Research Council, Ottawa, Ontario K1A 0R6, Canada,
¶ Department of Microbiology, University of Guelph, Guelph,
Ontario N1G 2W1, Canada, and ** Carlsberg Laboratory,
Department of Chemistry, Gamle Carlsberg Vej 10, DK-2500
Valby, Copenhagen, Denmark
Received for publication, March 20, 2002, and in revised form, April 29, 2002
 |
ABSTRACT |
Deamination of LPSs from Klebsiella
pneumoniae released O-chain polysaccharides together
with a fragment of the core oligosaccharide. The structures of the
products from serotypes O1, O2a, O2a,c, O3, O4, O5, and O12 were
determined by NMR spectroscopy and chemical methods, identifying the
linkage region between the O antigens and the core as well
as novel residues at the non-reducing ends of the polysaccharides. All
serotypes had an identical linkage between the O chain and
core.
 |
INTRODUCTION |
Like other members of the family Enterobacteriaceae, the
lipopolysaccharides (LPSs)1
of Klebsiella pneumoniae consist of three structural
domains, (i) the hydrophobic lipid A, which is a major component of the outer leaflet of the Gram-negative outer membrane, and (ii) the core
oligosaccharide, which is linked to lipid A and provides the attachment
site for (iii) the long chain polysaccharide (O antigen;
O chain). Typically, structural diversity is greater in the
regions of LPS extending from the cell surface (i.e. the O chains). Varying chemical structures in the O
chains gives rise to a number of serologically distinct O
antigens. In the Klebsiellae there are 11 known
O-chain structures, but structural similarities lead to some
serological cross-reactivities, so the actual number of unique O
serotypes is less (1, 2). Several of the O-antigens are
based on a structure designated D-galactan I with a repeat unit comprising
[-3)- -Galf-(1-3)- -Galp-(1-].2
When present alone, this structure provides the 2a antigen (3), but it can be capped by additional structural domains or modified by
side chain acetyl or galactosyl residues to generate additional unique
antigens (3-6). For example, in the most clinically prevalent serotype, the O1 antigen, D-galactan I chains are capped by
a domain with a different repeat unit structure,
[-3)- -Galp-(1-3)- -Galp-(1-] (D-galactan II). Genetic (7) and chemical (8, 9) analyses indicate that D-galactan I chains are linked directly to
the lipid A core structure, whereas D-galactan II is
confined to the distal end of some of the available
D-galactan I chains (10). D-Galactan II
provides the epitope(s) that defines the O1 antigen (9), and its
presence is required for the resistance of the bacteria to
complement-mediated killing in the host; K. pneumoniae
mutants that only produce D-galactan I are therefore
serum-sensitive (11, 12). However, not all Klebsiella
O serotypes are based on D-galactan I. The
prevalent O3 and O5 serotypes comprise mannan O chains with
structures identical to the Escherichia coli O9 and O8
antigens, respectively (13, 14). The remaining Klebsiella
O-chain structures are heteropolymers.
The biosynthesis of the polysaccharide O chain has been
investigated in some serotypes of K. pneumoniae by
biochemical and genetic experimental approaches. Much of the data for
the O3 and O5 serotypes is derived from the related equivalent systems
in E. coli. However, the genetic loci required for synthesis
of the corresponding O chain structures in E. coli (O8ec and O9ec) and K. pneumoniae (O5kp and O3kp, respectively)
are essentially identical and reflect lateral gene transfer events (15,
16). Biosynthesis data is also available for D-galactan I
(17, 18). These polymannans and polygalactans are polymerized by a
processive glycosyltransfer mechanism, i.e. sequential
addition of monosaccharides to the non-reducing end of the nascent
chain. Polymer growth occurs on a "primer" (or acceptor) consisting
of undecaprenyl pyrophosphoryl (und-PP)-linked GlcNAc. This compound is
formed by WecA, a UDP-GlcNAc:undecaprenyl phosphate GlcNAc-1-phosphate
transferase that forms und-PP-GlcNAc (19-21). Specific
mannosyltransferases or galactosyltransferases then extend the
und-PP-GlcNAc acceptor (17, 18, 21). The glycosyltransferase reactions
occur at the inner face of the cytoplasmic membrane, and once chain
extension is complete, the nascent O chain is transferred
across the cytoplasmic membrane by an ABC (ATP binding cassette)
transporter (21, 22). At the periplasmic face of the membrane, the
O chain is transferred from the lipid intermediate to
preformed lipid A core by the activity of the ligase enzyme
waaL to complete the LPS molecule (for review, see Refs. 23
and 24).
A crucial open question in the biosynthesis of these O
chains is the mechanism(s) by which the chain length is modulated. Examination of LPS molecules isolated from these bacteria shows a
typical "modal" (i.e. restricted) distribution of
O-chain lengths. The mechanism of LPS O-chain
length determination is crucial for the biology of these organisms
because it contributes to resistance to complement-mediated serum
killing. The O5kp and O8ec antigens have been
reported to contain 3-O-methyl-D-mannose at
their non-reducing termini (13), leading to speculation that terminal
structural elements may act as terminating signals for chain extension
(24). Other serotypes have not been investigated.
Recently we have found that polysaccharide O chain can be
detached from lipid A of K. pneumoniae LPS by treatment with
nitrous acid, which destroys the glycosidic linkage of the -GlcN
residue, present in the core oligosaccharide (25) (Fig.
1). The polysaccharides thus obtained
were short enough to allow direct structural determination of the end
groups by NMR spectroscopy. Here we present data of the analysis of the
end groups in the nitrous acid-released O chains from
K. pneumoniae serotypes O1, O2a, O2a,c, O3, O4, O5, and O12.
Most of these O chains have non-reducing terminal
modifications, suggesting this is a common feature in
Klebsiella O antigens. The data also identifies
the ligation site for O antigens in the LPS core and shows
it to be conserved in different serotypes.
where
L-glycero-D-manno-heptose
is non-stoichiometric. Analysis of the LPSs from a waaL
(O-polysaccharide ligase-deficient) mutant showed that the
-GlcNAc in the linkage region is derived from the
O-chain biosynthesis pathway, and the
-3-deoxy-D-manno-octulosonic acid represents
the core residue to which the O chain is ligated. Consistent with the common ligation site, the WaaL proteins from these
serotypes are essentially identical. Polysaccharides from serotypes O1,
O2a, and O2a,c contain no special groups at the non-reducing end,
whereas polysaccharides from serotypes O3, O4, O5, and O12 have
residues at the non-reducing end that are not found in the polymer
repeating units.
 |
EXPERIMENTAL PROCEDURES |
Bacterial Strains and Lipopolysaccharide Isolation--
K.
pneumoniae CWK2 (serotype O1:K20 ) has been described
elsewhere (9). The O-serotype reference strains, O3:K11
(strain 390), O4:K42 (1702), O5:K57 (4425/51), and O12:K80 (708) were provided by Dr. M. Trautmann (Department of Medical Microbiology and
Hygiene, University of Ulm, Germany). Cells of additional serotype O12
strains K. pneumoniae type strain 708 (O12:K80, NRCC 6136),
clinical isolate 134/94 (NRCC 6137), clinical isolate KD 420 (NRCC
6138), and clinical isolate 74/94 (NRCC 6139) were obtained from
Statens Seruminstitut (Copenhagen, Denmark). LPSs from smooth strains were isolated as described (26). To isolate LPSs from the
waaL mutant, K. pneumoniae strain CWG399
was grown in a fermenter (10L) in LB for 21h. The cells were
then harvested and lyophilized, and the LPS was extracted from dry
cells by the phenol/chloroform/light petroleum ether method of Galanos
et al. (27), with a yield of 5.8% of the bacterial dry mass.
Amplification of the waaL Genes from K. pneumoniae and Generation
of a Chromosomal waaL Mutation--
To analyze the sequences of the
waaL genes from serotypes O1, O3, O4, O5, and O12, the genes
were PCR-amplified from the appropriate strains with primers KPwaa1
(5'-GCGGCCTGGATCCGACCAACT-3') and KPwaa2
(5'-AGGCGAAGCAGGTACCCTGTGAAGA-3'). The primers were
based on the sequence of K. pneumoniae C3 (O1:K66)
waaL, available in GenBankTM (accession number
AF146532). The sequences of the waaL genes determined in
this work are available in GenBankTM as accession numbers
AF482003 (serotype O1, strain CWK2), AF482004 (O3), AF482005 (O4),
AF482006 (O5), and AF482007 (O12). The chromosomal
waaL gene in K. pneumoniae CWK2 (O1) was inactivated using a non-polar gentamicin (aacC1) resistance
cassette. To construct the waaL::aacC1
insertion, portions of the waaL gene and flanking DNA were
PCR-amplified from K. pneumoniae CWK2 chromosomal DNA using
PwoI polymerase. The products from primers KPwaa1 and KPwaa12 (5'-AGCATGATATCCACCGGCAGA-3') and KPwaa14
(5'-TCGCAGGGGATATCTATCATCAG-3') and KPwaa15
(5'-GGGATATCAGGTACCGGTGTTAAC-3') were digested with BamHI, EcoRV, and KpnI at sites
introduced by the primers (underlined) and ligated to BamHI
and KpnI sites in pBCSK+. This produced a construct
containing a waaL gene with a 503-bp deletion and an internal EcoRV site. The waaL deletion-derivative
gene and flanking DNA was removed on a BamHI and
KpnI fragment and ligated to a similarly digested
positive-selection suicide delivery vector that is based on pKO3 (28).
The SmaI-digested aacC1 cassette was then ligated
into the EcoRV site within waaL. This construct was transferred into CWK2 by electroporation, and allelic exchange was
generated a strain that was resistant to gentamicin (aacC1 insertion) and sensitive to chloramphenicol (i.e. loss of
vector). The resulting mutant was designated CWG399, and the correct
insertion was verified by PCR. To confirm that the mutant was only
defective in waaL activity, the mutation was complemented
using a plasmid carrying waaL. The waaL open
reading frame was PCR-amplified using PwoI and primers
Kpwaa1 and KPwaa2 (see above). The PCR fragment was ligated to vector
pRK404 (29) that was prepared by digestion with HindIII and
end-filled using Klenow. The resulting plasmid was designated pWQ161.
Nucleotide sequences were determined at the Guelph Molecular
Supercenter (University of Guelph, Guelph, ON, Canada).
Examination of LPSs by SDS-PAGE and Western
Immunoblotting--
For SDS-PAGE analysis, LPS was isolated from
proteinase K-digested whole cell lysates (30). The LPS was separated on
a 15% SDS-PAGE gel and visualized by silver staining and by Western immunoblot with rabbit anti-D-galactan I-specific
antibodies (17).
Preparation of the Polysaccharides Released by
Deamination--
The methods for deamination have been described
elsewhere (25). Briefly, LPS (200 mg) was dissolved in water (20 ml).
NaNO2 (100 mg) and acetic acid (1 ml) were then added, and
after a 6-h incubation at 25 °C, the lipid-containing part of the
LPS was removed by ultracentrifugation (120,000 × g,
2h). The supernatant was fractionated by gel filtration chromatography
on Sephadex G50 (superfine). Polysaccharides were purified on a
Hamilton PRP ×100 anion exchange high performance liquid
chromatography column in a gradient of 0-1 M NaCl, and the
collected peaks were desalted by gel filtration.
NMR Spectroscopy and General Methods--
Chemical shifts
obtained by NMR spectroscopy were assigned using two-dimensional homo-
and heteronuclear experiments at 799.96 MHz for proton and 201.12 MHz
for carbon using acetone as reference for proton (2.225 ppm) and
1,4-dioxane for carbon (67.4 ppm). Spectra were recorded at 40 °C in
D2O on a Varian UNITY INOVA 800 in 5-mm tubes. The double
quantum-filtered phase-sensitive COSY experiment was performed using
the Varian standard program tndqcosy, with 0.37-s acquisition time and
4096 data points in the F2 dimension. The data matrix was zero-filled
in the F1 dimension to give a matrix of 4096 × 2048 points and
was resolution-enhanced in both dimensions by a shifted sine-bell
function before Fourier transformation. Similarly, the nuclear
Overhauser experiment was performed using the Varian standard tnnoesy,
with a mixing time of 100 ms. The total correlation spectroscopy
experiment was performed using standard Varian program tntocsy with a
spinlock time of 80 ms. The heteronuclear experiments were performed
using standard pulse-field gradient programs gHSQC, gHSQCTOCSY, and
gHMBC. The spectra were assigned using the computer program Pronto
(31). Mass spectra were recorded by electrospray ionization Fourier transform-ion cyclotron mass spectrometry (ESI FT-ICR MS) utilizing an
Apex II with a 7-Tesla super-conducting magnet (Bruker Daltonics, Bremen, Germany). GLC, GLC-mass spectroscopy, methylation, and monosaccharide analyses were performed as previously described (32).
O-Deacylated LPSs were prepared by treatment of the LPS with
anhydrous hydrazine (1 ml for 50 mg of LPS, 40 °C, 1 h). After treatment, the samples were diluted with water and dialyzed.
 |
RESULTS |
Compositional Analysis of O-chain-containing LPS Fragments and
Determination of Repeating Unit Structures--
LPSs from K. pneumoniae serotypes O1, O2a, O2a,c, O3, O4, O5, and O12 were
treated with NaNO2/acetic acid, and the lipid A-containing part was removed by ultracentifugation. The soluble products were fractionated by gel and anion exchange chromatography to give polysaccharide fractions in addition to the two previously described (25) oligosaccharides 1 and 2, originating from O-chain-deficient LPS molecules.
The polysaccharide fractions were eluted from gel filtration
chromatography as one or two peaks of different molecular mass, and the
lower mass fractions were used for structural analysis. The
polysaccharides were passed through an anion exchange column in water,
and the void volume fractions were used in further studies; this
treatment significantly improved the quality of NMR spectra, removing
background signals derived from contaminants.
The monosaccharide analysis (GLC of alditol acetates) of the
polysaccharides (data not shown) revealed the presence of the expected
repeating unit monosaccharides (Fig. 2)
and of glucosamine and
L-glycero-D-manno-heptose
in quantities about 20 times less than those of the repeating unit
components. Monosaccharide analysis of the polysaccharide from serotype
O5kp also revealed small amount of
3-O-methylmannose, which was previously reported to be
present at the non-reducing end of the polymeric chain (13, 33). GLC analysis of the acetylated products of acid methanolysis of all polysaccharides showed the presence of Kdo.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 2.
Structures of the O-chain
glycans isolated from the deaminated LPSs of different K. pneumoniae serotypes. The serotypes are indicated on
the right. The repeating unit domains are boxed,
and with the exception of serotype O12, the structures are identical to
those already published in the literature. The O-repeating
units are defined from chemical and biosynthesis data. The
letter designation for the residues corresponds to the NMR
data in Tables I-VIII.
|
|
The polysaccharides were reduced with NaBH4 and
methylated, after which the methylated products were hydrolyzed
and converted to partially methylated 1d-alditol acetates. Gas
chromatography-mass spectrometry analysis led to the identification of
the major products derived from repeating units (Fig. 2) and a number
of small peaks of the intensity about 20-fold less than major products.
Among these minor products,
1,3,4-tri-O-methyl-6-O-acetyl-2,5-anhydromannitol, 2,3,4,6,7-penta-O-methyl-1,5-di-O-acetyl-1d-heptitol,
and
2-(N-methylacetamido)-2-deoxy-4,6-di-O-methyl-1,3,5-tri-O-acetyl-1d-glucitol were identified in all strains. These derivatives originated from the
monosaccharide residues M, P, and F at the reducing terminus. In serotype O12, the derivative of 3-substituted GlcNAc was present in a large proportion because it is also a component
of the repeating unit (34). Methylation of the polysaccharides from
serotypes O1, O2a, and O2a,c gave minor amounts of the derivatives of
non-substituted galactofuranose. Methylation of the polysaccharide from
serotype O12 showed the presence of minor amounts of non-substituted and 3-substituted rhamnopyranose. The methylated products obtained from
strain O5 contained
2,3,4,6-tetra-O-methyl-1,5-di-O-acetyl-1d-mannitol.
The NMR spectra of all polymers contained, in addition to the signals
of the components of repeating units, clearly visible signals of the
residues of Kdo and anomeric signals of Hep P and of the
hydrated aldehyde group of 2,5-anhydromannose (2,5-anhMan) (Figs. 3 and 4). The spectra were
interpreted using two-dimensional techniques, and most of the proton and carbon signals of repeating unit
monosaccharides were assigned. The signals of terminal regions were
well visible on the correlation spectra (Fig.
5) but could be only partially assigned
because of low signal intensities and overlap problems. Nevertheless,
1H and 13C NMR signals for atoms 1-5 were
found in most cases (Tables I-VIII), and
interglycoside NOE and HMBC correlations
were identified. These data were sufficient for the
identification of the constituent monosaccharides and for sequence
determination of the repeating unit and terminal
regions of the polymers. Monosaccharides
were identified on the basis of vicinal
coupling constants and chemical shifts of the signals, and their
connectivity was identified from NOE and HMBC data. Interglycoside NOE
correlations between H-1 and transglycosidic proton as well as adjacent
protons were observed. HMBC spectra contained correlations from H-1 to
the transglycosidic carbon atom, indicating linkage position, and
contained useful information for the signal assignment of
intraresidual correlations in -pyranoses to C-2 (weak) and C-3 and
C-5 (strong) and for -pyranose correlations to C-2 and C-3. For Kdo
residues, HMBC correlations from H-3 to its own C-2 and from C-2 to
transglycosidic carbon atom were identified.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 3.
1H NMR spectra of the
polysaccharides, obtained from K. pneumoniae serotypes
O1, O4, and O12. The lower trace shows the isolated
core oligosaccharide fragment found at the reducing end of the
polysaccharides.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 4.
1H NMR spectra of the
polysaccharides, obtained from K. pneumoniae
serotypes O3 and O5. Methyl group signals are denoted with
asterisks (*).
|
|

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 5.
Parts of the HSQC
1H,13C correlation spectrum of the
polysaccharide from K. pneumoniae O4.
Left, low level cut showing the signals of terminal
residues; right, high level cut, containing only signals of
the repeating unit.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
NMR data for the common part of the polysaccharides
Average chemical shifts for all analyzed polysaccharides ±0.02 ppm for
1H NMR and ±0.2 ppm for 13C NMR data are shown.
Residues marked a or b are derived from oligosaccharides with or
without -Hep (P; Fig. 2), respectively. anhMan,
2.5-anhydrimannose.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
NMR data for K. pneumoniae O1 polysaccharide
Residues marked with a "prime" belong to the non-reducing
end-repeating unit, whereas those residues marked a "double prime"
belong to the reducing end-repeating unit. Residues marked a or b are
derived from oligosaccharides with or without -Hep (P;
Fig. 2), respectively.
|
|
View this table:
[in this window]
[in a new window]
|
Table III
NMR data for K. pneumoniae O2a polysaccharide
Residues marked with a "prime" belong to the non-reducing
end-repeating unit, whereas those residues marked with a "double
prime" belong to the reducing end-repeating unit. Residues
marked a or b are derived from oligosaccharides with or without
-Hep (P; Fig. 2), respectively.
|
|
View this table:
[in this window]
[in a new window]
|
Table IV
NMR data for K. pneumoniae O2a,c polysaccharide
Residues marked with a "prime" belong to the non-reducing
end-repeating unit, whereas those marked with a "double prime" and
asterisk refer to residues in the reducing end-repeating unit and the
residue linking the two types of repeating units, respectively.
Residues marked a or b are derived from oligosaccharides with or
without -Hep (P; Fig. 2), respectively.
|
|
View this table:
[in this window]
[in a new window]
|
Table V
NMR data for K. pneumoniae O3 polysaccharide
Residues marked with a "prime" belong to the non-reducing
end-repeating unit. Residues marked a or b are derived from
oligosaccharides with or without -Hep (P; Fig. 2),
respectively.
|
|
View this table:
[in this window]
[in a new window]
|
Table VI
NMR data for K. pneumoniae O4 polysaccharide
Residues marked with a "prime" belong to the non-reducing
end-repeating unit, whereas those marked with a "double prime"
belong to the reducing end-repeating unit. Residues marked a or b are
derived from oligosaccharides with or without -Hep (P;
Fig. 2), respectively.
|
|
View this table:
[in this window]
[in a new window]
|
Table VII
NMR data for K. pneumoniae O5 polysaccharide
Residues marked with a "prime" belong to the non-reducing
end-repeating unit, whereas those marked with a "double prime"
belong to the reducing end-repeating unit. Residues marked a or b are
derived from oligosaccharides with or without -Hep (P;
Fig. 2), respectively.
|
|
View this table:
[in this window]
[in a new window]
|
Table VIII
NMR data for K. pneumoniae O12 polysaccharide
Residues marked with a "prime" belong to the non-reducing
end-repeating unit.
|
|
Structure of the Linkage Region between O Chain and Core
Oligosaccharide--
Detailed analysis of the spectra of all
polysaccharides revealed the presence of the same fragment at the
reducing end of each of the polymeric chains,
where P is H or -Hep (Table I). The residue
F was substituted either by a repeating unit (serotypes O1,
O2a, O2a,c, O3, O4, O12) or by another fragment (serotype O5).
Linkage Region Structure in the Glycan from Serotype O1--
NMR
analysis of the polysaccharide derived from K. pneumoniae O1
LPSs revealed that the structure of the O chain was as
described previously (9, 11). It consisted of two types of repeating units, [-3)- -Galf-(1-3)- -Galp-(1-]
(D-galactan I) and
[-3)- -Galp-(1-3)- -Galp-(1-] (D-galactan II), with the D-galactan I attached
to -GlcNAc F residue at position 3. D-Galactan II was found attached to the non-reducing end of
some D-galactan I chains. No structural elements that are
not components of the repeating units were found either between
galactan I and galactan II or at the non-reducing end of the
polysaccharide chain. Although structures with variable lengths of
D-galactan II are present, the shortest fractions, containing 0-3 repeating units of D-galactan II, were used
for NMR structural analysis. Molecules with higher molecular weights did not yield spectra with well resolved terminal residues. Both terminal galactofuranose and galactopyranose were found in methylation analysis, showing that populations of the polymer can have either D-galactan I or D-galactan II units at the
non-reducing end, in support of previous results (9, 10). NMR analysis
identified Galf as the non-reducing terminal residue in
those O chains lacking D-galactan II, but the
expected terminal Galp residues from molecules containing
D-galactan II could not be resolved in the spectra. The NMR
data were consistent with a direct linkage between the Galp
residue of the first repeating unit and -GlcNAc (residue F) of the core linkage region.
The structure of the O1 polymer was confirmed by electrospray
ionization mass spectrometry data (Fig.
6). The mass spectrum contained a number
of signals with maximum at 4151.4 Da, corresponding to 11 repeating
units with the expected fragment with non-hydrated 2,3-anhydromannose
residue at the reducing end; signals of the polymers with 9-16
repeating units were observed. Two series of signals were present,
reflecting partial substitution with Hep residue P.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 6.
Mass spectrum of the polysaccharide, obtained
by deamination of the K. pneumoniae O1 LPS. The
numbers indicate the numbers of repeating units in a given
molecular species. Peaks marked with a (+) reflect molecular species
where residue P is a heptose, whereas species with a
hydrogen at residue P are unmarked.
|
|
Linkage Region Structure in the Glycan from Serotype O2a--
As
reported previously, this polymer had only the galactan I type of
repeating units (3, 6). The non-reducing end of the polymer was
comprised of a residue of Galf, in agreement with the
results from D-galactan I chains in the O1 antigen.
Linkage Region Structure in the Glycan from Serotype
O2a,c--
The analysis of the O2a,c polymer revealed the same two
repeating units reported previously reported (3),
[-5)- -Galf-(1-3)- -GlcNAc-(1-] (2c antigen) and
[-3)- -Galf-(1-3)- -Galp-(1-]
(D-galactan I). D-Galactan I chains were linked
to -GlcNAc F, and the 2c antigen was found at the
non-reducing terminus of some D-galactan I chains. As in
the case of the serotypes O1 and O2a, the structure of the polymer
contained no unique residues at the non-reducing terminus. The only
detectable terminal residue was Galf, and this could arise
from either repeating unit. No novel residues were detected between two
types of the repeating units.
Linkage Region Structure in the Glycan from Serotype
O3--
Analysis of the polymer from serotype O3 revealed the presence
of the previously described repeating unit (35). NMR spectra of this
polysaccharide as well as of the polymer obtained from O3 LPS by
conventional mild acid hydrolysis contained the signals of two methyl
groups ( H/ C, 3.55/54.1, 3.56/54.0 ppm)
(Fig. 4). The intensities of these signals were consistent with their
presence at the end of the polymeric chain. However, the origin of
these signals remained unclear. No methylated monosaccharides were
detected in GLC-mass spectrometry analysis of the alditol acetates,
alditol acetates obtained from the dephosphorylated polysaccharide, or acetylated products of the methanolysis of the polysaccharide. Furthermore, no components other than mannose, glucosamine,
D,L-heptose, and Kdo were detected by
conventional analytical methods. The methyl signals gave no NOE to any
proton and no HMBC correlations, in contrast to what is normally
observed for the methyl groups present as ether substituents
(e.g. in the polymer from serotype O5).
Interestingly, the same signals are visible on the published 1H NMR spectrum of the polymer from Hafnia
alvei, which was found to be identical to the
Klebsiella O3 and E. coli O9 polysaccharides (36). Methylation analysis of the O3 polymer showed the presence of a
very small amount of terminal mannose, which was not detected in the
NMR spectra. One modified mannose residue, T, can be
identified, but the nature of modification could not be resolved by
currently available methods nor could the frame for the repeating unit
be identified from the NMR data. The residues N and Q between the repeating unit and GlcNAc F
probably do not belong to the repeating unit and are similar to
analogous residues in the serotype O5 polysaccharide. This conclusion
agrees with genetic and biosynthesis data.
Linkage Region Structure in the Glycan from Serotype O4--
The
polymer obtained from Klebsiella O4 contained the previously
described repeating unit (37). NMR data showed that it is linked
directly to the GlcNAc F through an -Gal residue. The
1H NMR spectrum contained additional signals from a Kdo
residue (Fig. 3). Comparison of the NMR data for this Kdo residue with published data for methyl - and -pyranosides identified it as having -pyranose configuration (38). HMBC correlation between Kdo
C-2 (identified from HMBC correlation to H-3 protons) and Ribf H-2 identified the non-reducing terminus as
-Kdo-(2-2)- -D-Ribf.
Linkage Region Structure in the Glycan from Serotype O5--
NMR
data for the serotype O5 polysaccharide (Fig. 4) revealed the presence
of the previously described repeating unit as well as a
3-O-methylated mannose residue (13). However, the repeating unit domain was not linked directly to the -GlcNAc F
residue. Instead, the structure contains a bridging disaccharide
located between the repeating unit and GlcNAc F.
The non-reducing end of the polymer was represented by the residue
of 3-O-methyl- -mannopyranose residue T, which
does not belong to the repeating unit. The position of the methyl group was identified using NOE correlation.
Linkage Region Structure in the Glycan from Serotype O12--
The
structure of the repeating unit of the polysaccharide from serotype O12
differed from that previously published, in which the rhamnose residue
was reported to be substituted at position 3 (34):
[-3)- -GlcNAc-(1-3)- -Rha-(1-].
Methylation analysis showed the presence of 3-substituted
N-acetylglucosamine and 4-substituted rhamnose residues as
major components, and this was confirmed by NMR experiments. NOE and HBMC data revealed a repeating unit containing rhamnose residues substituted at position 4. A small amount of 3-substituted rhamnose detected in methylation analysis is derived from the terminal region of
the polymer. To eliminate the possibility that the differences in the two O12 structures reflected different sources of LPS isolation, LPSs from four additional isolates of K. pneumoniae serotype
O12 were examined. These included the type strain 708 (serotype
O12:K80) from Statens Seruminstitut (Denmark) collection used for the
structure in the published literature (34) and three other clinical
isolates (see "Experimental Procedures"). All isolated
polysaccharides had the same repeating unit structure containing
4-substituted Rha residues. The revised O12 repeating unit structure is
therefore [-3)- -D-GlcNAc-(1-4)- -L- Rha-(1-].
No additional monosaccharides were found between the repeating
unit and GlcNAc F. The polymer contained a residue of Kdo at
the non-reducing end (Fig. 2) and NMR data for this Kdo residue showed
a -pyranose configuration (38). As in the case of the serotype O4,
the attachment position of Kdo was found on the basis of the observed
HMBC correlation between C-2 of Kdo residue and H-3 of rhamnose residue
A'. The terminal residue of -Kdo is thus linked to
O-3 of the Rha residue, whereas Rha present within the
repeating unit itself is substituted at position 4. A small amount of
non-substituted Rha was evident, derived from the few chains lacking
the terminal -Kdo.
The electrospray ionization mass spectrum of the polymer contained, as
in the case of O1 polysaccharide, two series of peaks due to the
partial presence of Hep P at 5493 (no Hep P), 5684 (with Hep P), 5842, 6034, 6191, and 6384 Da,
corresponding to the molecules containing 13-15 repeating units (data
not shown). Masses corresponded to equal number of Rha and GlcNAc
residues, which indicates that Rha A', substituted with Kdo,
does not belong to the repeating unit.
Structure of the Core Oligosaccharide in CWG399, an O-antigen
Ligase-deficient Mutant--
To unequivocally determine which residues
in the linkage region are derived from the core and which are provided
by the O-chain biosynthesis pathway, an O-chain
ligase-deficient waaL mutant was constructed by allelic
exchange. Within the waa locus reported from K. pneumoniae serotype O1:K66 is one open reading frame predicting a
protein that resembles known WaaL proteins. These proteins all have
multiple transmembrane segments and a characteristic periplasmic domain
toward the C terminus and are, therefore, readily identified by
examination of hydrophobicity-hydrophilicity plots (Fig.
7A). To confirm its identity,
the waaL gene from K. pneumoniae serotype O1 was
mutated with a non-polar cassette in strain CWG399. As expected, the
waaL mutant lacked smooth LPSs containing the O1 antigen due
to the ligation defect (Fig. 7B). The LPS from CWG399 was
isolated and de-O-acylated, and the products were subjected to mass spectrometry. The resulting spectrum (Fig. 7C)
resembled that seen from the subset of rough (O-deficient)
LPS isolated from strains with predominantly smooth
(O-substituted) LPS. The largest major peak with mass ion
3057.9 corresponds to an LPS molecule containing the entire core
structure. The remaining species reflect the variable substitution with
-GalA and -D,L-Hep residues, and these
structures have already been documented (26). Ligation could be
restored in CWG399 by the addition of pWQ161 carrying the wild-type
waaL gene. As this data was being completed, a similar mutation/complementation approach was used to confirm the identity of
waaL in the O1:K66 isolate, although the structure of the
LPS in the mutant was not determined (39). The core structure for CWG399 lacks the O chain as expected as well as the
-GlcNAc residues found in the linkage site structure.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 7.
Characterization of the LPS in a waaL
(O-antigen ligase-deficient) mutant of K. pneumoniae. Panel A, the waaL
gene encoding the O-antigen ligase was identified from the
GenBankTM accession (AF146532) for the waa locus
from K. pneumoniae strains C3 (O1:K66), based on the
characteristic hydropathy profile shared with other known ligases such
as the one from E. coli core type R1 (53). The gene was
mutated by allelic exchange to generate strain CWG399. Panel
B shows the PAGE profile of LPS from the waaL mutant
(CWG399) and its parent (CWK2), demonstrating the loss of high
molecular weight O-chain-substituted LPS in the mutant and
the restoration of the wild-type LPS profile by plasmid pWQ161-encoded
waaL. The immunoblot was developed using rabbit polyclonal
serum raised against the D-galactan I component of the
O polysaccharide. Panel C shows the mass spectrum
obtained from the de-O-acylated LPS of K. pneumoniae CWG399 and the deduced structure of the core
oligosaccharide. Residues J, K, and P
are all non-stoichiometric additions as reported previously (26) and
lead to the heterogeneity in core structures derived from CWG399.
|
|
Identification of a Conserved waaL gene in K. pneumoniae--
The
waaL genes were amplified by PCR from K. pneumoniae serotypes O1, O3, O4, O5, and O12, and the sequences
were determined. The sequences for the two predicted waaL
proteins from the O1 isolates shared 97.5% identity and 98.9% overall
similarity. When the O1 sequence (from CWK2) was compared with the
predicted proteins from the other serotypes, similarly high levels of
conservation were found: O3kp (99.7% identity; 100%
overall similarity), O4kp (99.7%; 100%), O5kp
(98.1%; 99.4%), and O12kp (96.1%; 98.9%). A partial
waaL sequence is also available from the in progress K. pneumoniae genome project
(genome.wustl.edu/gsc/Projects/K.pneumoniae), although the O
serotype of the source strain (MGH78578) is apparently unknown. This
sequence also shows a very high level of conservation.
 |
DISCUSSION |
Previously we reported that the rough
(O-chain-deficient) LPS fractions isolated from K. pneumoniae serotypes O1, O2, O3, O4, O5, O8, and O12
contain a conserved fragment that is released by deamination with
nitrous acid, converting GlcN (residue M) into
anhydro-mannose residue (26) (Fig. 1). Here we show that this
structural motif forms part of a linkage region between the core
oligosaccharide and the repeating unit domain of the O chain with the structure below.
The -GlcNAc was not detected in the products derived from the
core oligosaccharide in previous studies, suggesting that it forms part
of the O-chain polysaccharide. Conclusive evidence for this
proposal was obtained by the absence of -GlcNAc in the core
oligosaccharide isolated from the O-antigen ligase
(waaL)-deficient mutant CWG399, which by definition, must
have a complete core. To our knowledge this is the first definitive
structure from a K. pneumoniae strain with a genetically
defined LPS defect. Previous analyses have involved core fractions
isolated from strains with smooth LPS or cores from undefined mutants
lacking O chains and could therefore represent truncated
structures. The observation of a conserved linkage region in the LPS of
different Klebsiella serotypes is consistent with the
finding that the LPS core oligosaccharides of isolates representing
different O serotypes share a common epitope recognized by a monoclonal
antibody, although the precise epitope has not been identified
(40).
Biosynthesis of the D-galactan I O chain from
serotype O1kp (17) and the polymannan O8ec and
O9ec antigens (which are identical to O5kp and
O3kp, respectively) (41) all occur on an und-PP-GlcNAc primer. The original in vitro studies involving the
polymannans identified a requirement for the Rfe enzyme (now renamed as
WecA) in O-chain assembly and pointed to und-PP-Glc as a
possible primer (41-44). It was proposed that the Glc residue at the
reducing terminus of the mannan was transferred to the lipid A core
with the mannan in the ligation reaction (45). However, subsequent
analysis of the role of WecA in enterobacterial common antigen
synthesis established the enzyme as being a UDP-GlcNAc:undecaprenyl
phosphate GlcNAc-1-phosphate transferase (19). Consistent with this
assignment, in vivo studies with the O8ec
confirmed the involvement of und-PP-GlcNAc as the primer (20). Later
biosynthesis experiments with the O9 antigen resolved the contradictory
literature by showing that both und-PP-Glc and Und-PP-GlcNAc could
serve as primers for in vitro mannan assembly with
und-PP-GlcNAc being more efficient (21). The synthesis of und-PP-Glc in
the original work was presumably due to the reaction conditions
employed and relaxed specificity of WecA in vitro. The
definitive structure of the linkage domain between the O
chain and core oligosaccharide and the structure of CWG399 LPS confirms
und-PP-GlcNAc as the donor of the -GlcNAc residue located at the
reducing terminus of the glycan chain in Klebsiella. The
definitive structure of the linkage domain between the O
chain and core oligosaccharide and the structure of CWG399 LPS confirms
und-PP-GlcNAc as the donor of the -GlcNAc residue located at the
reducing terminus of the glycan chain. From the structure presented
here, the und-PP-linked O chain in each serotype is extended
from a reducing terminal -GlcNAc and is then transferred to an
identical attachment site in the core. Consequently, the waaL (O-antigen ligase) enzyme in each serotype
would perform an identical reaction, therefore explaining the high
degree of identity found in the predicted waaL proteins from
K. pneumoniae serotypes O1, O3, O4, O5, and O12
(96.1-99.7%).
Analysis of the structure of the core-attachment region and repeat-unit
structure of these O serotypes provides additional insight into the
biosynthetic process. In the O1, O2a, O2a,c, O4, and O12 polymers,
there is a direct transition from the primer GlcNAc into the first
chemically defined repeat unit of the O chain. However, with
the exception of O12, dedicated glycosyltransferase activities must be
necessary for the addition of the first residue of the repeating unit
onto the GlcNAc primer, because the resulting linkage is not found
elsewhere in the O chain. For example, in the biosynthesis
of D-galactan I, the bifunctional WbbO enzyme transfers one residue each of Galp and Galf to
und-PP-GlcNAc to form the structure
-3)- -Galf-(1-3)- -Galp-(1-3)-GlcNAc (18). In subsequent chain extension, only the galactofuranosyl activity of
WbbO participates in repeating unit synthesis and an additional enzyme
(WbbM) provides galactopyranosyltransferase activity. From a
biosynthetic perspective, the initial Galp residue forms an "adaptor" that is extended by multiple rounds of processive
glycosyltransferase activity to form the repeat unit domain. Genetic
and biosynthesis data are not available for the O4kp and
O12kp O chains, but the structures of the
deamidation-released glycans provide some insight. In serotype
O4kp, it is evident that there is a requirement for one
galactosyltransferase activity that acts once per O chain to
form -Gal-(1-3)- -GlcNAc in the adaptor region and another Gal
transferase that generates -Gal-(1-2)- -Ribf linkages
in the repeat unit. In contrast, the presence of GlcNAc within the repeating unit of serotype 12 affords the possibility that a single rhamnosyltransferase adds Rha residues to either the primer GlcNAc or a
GlcNAc residue within the repeating unit.
The biosynthetic pathways for the O3 and O5 polymannans both
involve the same primer-adaptor sequence with the structure below.
Biosynthetic data obtained from the E. coli polymannose
antigens can be directly related to O5kp and
O3kp, because the relevant biosynthetic enzymes
are conserved. In the prototype O9aec system, the
WbdC (formerly MtfC) mannosyltransferase transfers the initial mannosyl residue to und-PP-GlcNAc (21). This reaction occurs only once
per polymannose chain, so the resulting residue (Q, Fig. 2)
does not form part of the repeat unit. The next transfer is mediated by
WbdB (formerly MtfB), which is proposed to add 2 -(1-3)-linked
mannosyl residues (21). Examination of data base sequences shows that
the WbdA and WbdC proteins from E. coli serotypes O8, O9a,
and O9 and Klebsiella O3 and O5 are virtually identical
(>95%). Furthermore, the WbdB-WbdC pairs from E. coli O9a
and O8 are functionally
interchangeable.3 From this
collective data, WbdC and WbdB appear to play identical roles in the
initial biosynthetic steps of each member of this polymannose
O-chain family. After formation of this adaptor, the pathways for biosynthesis of the repeating unit domains of the polymannan O chains diverge. In O9ec
(O3kp), the repeat unit is apparently formed by the
activities of WbdB and WbdA. Defined sequence changes in the WbdA
homologues (46) result in structural differences between
O9ec (O3kp) and a variant (O9aec)
containing a tetrasaccharide repeat unit differing by one
-(1-2)-linked mannosyl residue from the pentasaccharide in
O9ec/O3kp. WbdA is capable of adding blocks of
-(1-2)-linked mannosyl residues, presumably 2 in O9aec
and 3 in O9ec (O3kp). The proposed biosynthetic pathway suggests that polymer extension occurs by alternating activities of WbdB and WbdA, but definitive proof of such an
alternating mechanism is not yet available. The gene cluster for
O8ec/O5kp biosynthesis lacks wbdA,
and the sequences of these parts of the O-antigen
biosynthesis loci differ. Differences in the sequences of
glycosyltransferases would be expected because the
O8ec/O5kp antigen contains a -linked mannose
in its repeating unit. It seems unlikely that WbdB is involved in later
chain extension stages of O8ec/O5k synthesis
because, unlike the O9ec/O3kp polymers, there
is no -Man-(1-3)- -Man linkage within the repeat unit.
Despite differences in enzyme specificities, the requirement for a
specific glycosyltransferase in forming an adaptor region between the
-GlcNAc and the repeat unit domain of the O chain is a
common feature in the K. pneumoniae polysaccharides studied here and is likely to be involved in all polymers whose assembly involves processive glycosyl transfer.
The mechanism that regulates O chain length in processive
synthesis mechanisms is unknown (23). The observation that the O8ec/O5kp polymannans have
3-O-methylmannose at their reducing termini led to
speculation that such residues act as molecular markers for chain
termination (13). We are aware of two other examples where a modified
residue is found at the non-reducing terminus of an O chain.
One is in Vibrio cholerae, O1 where 2-O-methyl groups are found (47). Although V. cholerae mutants lacking this residue are not impaired in the ability to synthesize O
antigen, they do lose the epitope associated with seroconversion from
type Ogawa to Inaba (48). In the O polysaccharide of Bordetella
bronchiseptica, a unique
2,3,4-triamino-2,3,4-trideoxy- -galacturonamide derivative is found
at the chain terminus (49). The observation that the O4kp
and O12kp O chains terminate in Kdo residues
extends the range of known terminal modifications to include glycosyl
residues. The K. pneumoniae O1 and O2a,c provide somewhat
different situations in which a D-galactan I chain is
capped by an additional structural domain rather than a single residue.
It is not yet clear whether this is an extreme form of chain
termination, but in the absence of such capping in mutants lacking
D-galactan I or in other isolates with the O2a antigen, the
size distribution of D-galactan I differs (9).
Gene content and, in some cases, functional analyses of their
respective O-chain biosynthesis loci, provide insight into a common feature in the biosynthesis of O antigens in V. cholerae O1 (36), B. bronchiseptica (52), and
Klebsiella O3 and O5 (and O8ec and
O9ec) (21). These O chains are assembled by an ABC transporter-dependent mechanism in which the
transporter exports nascent polymer across the cytoplasmic membrane to
the periplasm where ligation occurs (for review, see Ref. 24). The
presence of non-reducing terminal modifications may therefore provide a unifying theme in the biosynthesis of O chains that are
extended by processive glycosyltransfer to the non-reducing terminus.
This process clearly differs from the other major pathway for
O-antigen biosynthesis. In the Wzy-dependent
pathway, und-PP-linked repeating units provide substrates for a
blockwise polymerization mechanism that minimally involves the Wzy
protein. Growth of the und-PP-linked glycan occurs by the addition of
repeating units to the reducing terminus and the polymerization
reaction occurs at the periplasmic face of the inner membrane (for
review, see Ref. 24). The Wzz protein is required for chain-length
determination in this pathway, and it is thought to coordinate the
activity of the polymerase, O-antigen ligase, or both by a
mechanism that has yet to be elucidated (for review, Ref. 23). There is
no requirement for novel non-reducing terminal residues to delineate
chain termination in the Wzy-dependent pathway, and none
have been identified in structural analyses of many representative
O antigens.
The termination of O chains at a specific residue explains
the observation that purified smooth LPS from these bacteria gives rise
to a typical ladder of molecules on SDS-PAGE, with the molecules differing by increments of one repeat unit. In contrast, chain completion at any residue would yield a distribution in size increments of a single glycosyl residue, resulting in an unresolved smear on
SDS-PAGE. Although the terminal modifications may provide a mechanism
of chain termination in polymers that grow by processive transfer of
glycosyl residues to the non-reducing terminus, a crucial open question
is how the process is regulated. The presence and chain length of the
LPS O chain plays a critical role in the resistance of
Klebsiella to complement-mediated serum killing (11, 12, 50,
51). Thus the regulation of O-chain termination represents
an important element in the biology of significant pathogens like
K. pneumoniae.
 |
ACKNOWLEDGEMENTS |
We thank Donald Krajcarsky (National Research
Council, Canada) and Buko Lindner (Forschungszentrum Borstel,
Federal Republic of Germany) for contributions to mass spectrometry
analysis. The spectra at 800 MHz were obtained at the Varian Unity
Inova spectrometer of the Danish Instrument Center for NMR Spectroscopy
of Biological Macromolecules.
 |
FOOTNOTES |
*
This work was supported by funding from the Canadian
Bacterial Diseases Network (to M. B. P. and C. W.) and the Natural
Sciences and Engineering Research Council (to C. W.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Inst. for Biological
Sciences, National Research Council, 100 Sussex Dr., Ottawa, ON K1A
0R6, Canada. Tel.: 613-990-03-97; Fax: 613-952-90-92; E-mail: evguenii.vinogradov@nrc.ca.
Supported by a Postgraduate Scholarship from the Natural
Sciences and Engineering Research Council.

This author acknowledges receipt of a Canada Research Chair award.
Published, JBC Papers in Press, April 30, 2002, DOI 10.1074/jbc.M202683200
2
All monosaccharides have the D
configuration except L-Rha.
3
P. Amor and C. Whitfield, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
LPS, lipopolysaccharide;
Hep, L-glycero-D-manno-heptose;
GalA, galacturonic acid;
Kdo, 3-deoxy-D-manno-octulosonic acid;
P, phosphate;
und-PP, undecaprenyl pyrophosphoryl;
NOE, nuclear Overhauser effect;
HMBC, heteronuclear multiple bond coherence.
 |
REFERENCES |
| 1.
|
Hansen, D. S.,
Mestre, F.,
Alberti, S.,
Hernandez-Alles, S.,
Alvarez, D.,
Domenech-Sanchez, A.,
Gil, J.,
Merino, S.,
Tomas, J. M.,
and Benedi, V. J.
(1999)
J. Clin. Microbiol.
37,
56-62[Abstract/Free Full Text]
|
| 2.
|
Trautmann, M.,
Ruhnke, M.,
Rukavina, T.,
Held, T. K.,
Cross, A. S.,
Marre, R.,
and Whitfield, C.
(1997)
Clin. Diagn. Lab. Immunol
4,
550-555[Abstract]
|
| 3.
|
Whitfield, C.,
Perry, M. B.,
MacLean, L. L.,
and Yu, S. H.
(1992)
J. Bacteriol.
174,
4913-4919[Abstract/Free Full Text]
|
| 4.
|
Kelly, R. F.,
Severn, W. B.,
Richards, J. C.,
Perry, M. B.,
MacLean, L. L.,
Tomas, J. M.,
Merino, S.,
and Whitfield, C.
(1993)
Mol. Microbiol.
10,
615-625[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
MacLean, L. L.,
Whitfield, C.,
and Perry, M. B.
(1993)
Carbohydr. Res.
239,
325-328[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Kelly, R. F.,
MacLean, L. L.,
Perry, M. B.,
and Whitfield, C.
(1995)
J. Endotoxin Res.
2,
131-140
|
| 7.
|
Clarke, B. R.,
and Whitfield, C.
(1992)
J Bacteriol.
174,
4614-4621[Abstract/Free Full Text]
|
| 8.
|
Kol, O.,
Wieruszeski, J. M.,
Strecker, G.,
Fournet, B.,
Zalisz, R.,
and Smets, P.
(1992)
Carbohydr. Res.
236,
339-344[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Whitfield, C.,
Richards, J. C.,
Perry, M. B.,
Clarke, B. R.,
and MacLean, L. L.
(1991)
J. Bacteriol.
173,
1420-1431[Abstract/Free Full Text]
|
| 10.
|
Kol, O.,
Wieruszeski, J. M.,
Strecker, G.,
Montreuil, J.,
and Fournet, B.
(1991)
Carbohydr. Res.
217,
117-125[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
McCallum, K. L.,
Schoenhals, G.,
Laakso, D.,
Clarke, B.,
and Whitfield, C.
(1989)
Infect. Immun.
57,
3816-3822[Abstract/Free Full Text]
|
| 12.
|
McCallum, K. L.,
Laakso, D. H.,
and Whitfield, C.
(1989)
Can. J. Microbiol.
35,
994-999[Medline]
[Order article via Infotrieve]
|
| 13.
|
Jansson, P. E.,
Lonngren, J.,
Widmalm, G.,
Leontein, K.,
Slettengren, K.,
Svenson, S. B.,
Wrangsell, G.,
Dell, A.,
and Tiller, P. R.
(1985)
Carbohydr. Res.
145,
59-66[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Prehm, P.,
Jann, B.,
and Jann, K.
(1976)
Eur. J. Biochem.
67,
53-56[Medline]
[Order article via Infotrieve]
|
| 15.
|
Sugiyama, T.,
Kido, N.,
Kato, Y.,
Koide, N.,
Yoshida, T.,
and Yokochi, T.
(1997)
Gene
198,
111-113[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Sugiyama, T.,
Kido, N.,
Kato, Y.,
Koide, N.,
Yoshida, T.,
and Yokochi, T.
(1998)
J. Bacteriol.
180,
2775-2778[Abstract/Free Full Text]
|
| 17.
|
Clarke, B. R.,
Bronner, D.,
Keenleyside, W. J.,
Severn, W. B.,
Richards, J. C.,
and Whitfield, C.
(1995)
J. Bacteriol.
177,
5411-5418[Abstract/Free Full Text]
|
| 18.
|
Guan, S.,
Clarke, A. J.,
and Whitfield, C.
(2001)
J. Bacteriol.
183,
3318-3327[Abstract/Free Full Text]
|
| 19.
|
Meier-Dieter, U.,
Starman, R.,
Barr, K.,
Mayer, H.,
and Rick, P. D.
(1990)
J. Biol. Chem.
265,
13490-13497[Abstract/Free Full Text]
|
| 20.
|
Rick, P. D.,
Hubbard, G. L.,
and Barr, K.
(1994)
J. Bacteriol.
176,
2877-2884[Abstract/Free Full Text]
|
| 21.
|
Kido, N.,
Torgov, V. I.,
Sugiyama, T.,
Uchiya, K.,
Sugihara, H.,
Komatsu, T.,
Kato, N.,
and Jann, K.
(1995)
J. Bacteriol.
177,
2178-2187[Abstract/Free Full Text]
|
| 22.
|
Bronner, D.,
Clarke, B. R.,
and Whitfield, C.
(1994)
Mol. Microbiol.
14,
505-519[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Whitfield, C.,
Amor, P. A.,
and Koplin, R.
(1997)
Mol. Microbiol.
23,
629-638[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Whitfield, C.
(1995)
Trends Microbiol.
3,
178-185[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Vinogradov, E. V.,
Cedzynski, M.,
Ziolkowski, A.,
and Swierzko, A.
(2001)
Eur. J. Biochem.
268,
1722-1729[Medline]
[Order article via Infotrieve]
|
| 26.
|
Vinogradov, E.,
and Perry, M. B.
(2001)
Carbohydr. Res.
335,
291-296[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Galanos, C.,
Lüderitz, O.,
and Westphal, O.
(1969)
Eur. J. Biochem.
9,
245-249[Medline]
[Order article via Infotrieve]
|
| 28.
|
Link, A. J.,
Phillips, D.,
and Church, G. M.
(1997)
J. Bacteriol.
179,
6228-6237[Abstract/Free Full Text]
|
| 29.
|
Ditta, G.,
Schmidhauser, T.,
Yakobson, E., Lu, P.,
Liang, X. W.,
Finlay, D. R.,
Guiney, D.,
and Helinski, D. R.
(1985)
Plasmid
13,
149-153[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Hitchcock, P. J.,
and Brown, T. M.
(1983)
J. Bacteriol.
154,
269-277[Abstract/Free Full Text]
|
| 31.
|
Kjaer, M.,
Andersen, K. V.,
and Poulsen, F. M.
(1994)
Methods Enzymol.
239,
288-308[Medline]
[Order article via Infotrieve]
|
| 32.
|
Unger, F. M.
(1981)
Adv. Carbohydr. Chem. Biochem.
38,
323-388
|
| 33.
|
Lindberg, B.,
Lonngren, J.,
and Nimmich, W.
(1972)
Acta Chem. Scand.
26,
2231-2236[Medline]
[Order article via Infotrieve]
|
| 34.
|
Erbing, C.,
Lindberg, B.,
and Lonngren, J.
(1977)
Carbohydr. Res.
56,
377-381[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Curvall, M.,
Lindberg, B.,
Loenngren, J.,
and Nimmich, W.
(1973)
Acta Chem. Scand.
27,
2645-2649[Medline]
[Order article via Infotrieve]
|
| 36.
|
Manning, P. A.,
Stroeher, U. H.,
Karageorgos, L. E.,
and Morona, R.
(1995)
Gene
158,
1-7[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Bjorndal, H.,
Lindberg, B.,
Lonngren, J.,
Nilsson, K.,
and Nimmich, W.
(1972)
Acta Chem. Scand.
26,
1269-1271[Medline]
[Order article via Infotrieve]
|
| 38.
|
Birnbaum, G. I.,
Roy, R.,
Brisson, J. R.,
and Jennings, H. J.
(1987)
J. Carbohydr. Chem.
6,
17-39
|
| 39.
|
Regue, M.,
Climent, N.,
Abitiu, N.,
Coderch, N.,
Merino, S.,
Izquierdo, L.,
Altarriba, M.,
and Tomas, J. M.
(2001)
J. Bacteriol.
183,
3564-3573[Abstract/Free Full Text]
|
| 40.
|
Trautmann, M.,
Vogt, K.,
Hammack, C.,
and Cross, A. S.
(1994)
Infect. Immun.
62,
1282-1288[Abstract/Free Full Text]
|
| 41.
|
Jann, K.,
Kanegasaki, S.,
Goldemann, G.,
and Makela, P. H.
(1979)
Biochem. Biophys. Res. Commun.
86,
1185-1191[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Jann, K.,
Goldemann, G.,
Weisgerber, C.,
Wolf-Ullisch, C.,
and Kanegasaki, S.
(1982)
Eur. J. Biochem.
127,
157-164[Medline]
[Order article via Infotrieve]
|
| 43.
|
Jann, K.,
Pillat, M.,
Weisgerber, C.,
Shibaev, V. N.,
and Torgov, V. I.
(1985)
Eur. J. Biochem.
151,
393-397[Medline]
[Order article via Infotrieve]
|
| 44.
|
Weisgerber, C.,
and Jann, K.
(1982)
Eur. J. Biochem.
127,
165-168[Medline]
[Order article via Infotrieve]
|
| 45.
|
Weisgerber, C.,
Jann, B.,
and Jann, K.
(1984)
Eur. J. Biochem.
140,
553-556[Medline]
[Order article via Infotrieve]
|
| 46.
|
Kido, N.,
and Kobayashi, H.
(2000)
J. Bacteriol.
182,
2567-2573[Abstract/Free Full Text]
|
| 47.
|
Ito, T.,
Higuchi, T.,
Hirobe, M.,
Hiramatsu, K.,
and Yokota, T.
(1994)
Carbohydr. Res.
256,
113-128[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Stroeher, U. H.,
Karageorgos, L. E.,
Morona, R.,
and Manning, P. A.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
2566-2570[Abstract/Free Full Text]
|
| 49.
|
Vinogradov, E.,
Peppler, M. S.,
and Perry, M. B.
(2000)
Eur. J. Biochem.
267,
7230-7237[Medline]
[Order article via Infotrieve]
|
| 50.
|
Merino, S.,
Camprubi, S.,
Alberti, S.,
Benedi, V. J.,
and Tomas, J. M.
(1992)
Infect. Immun.
60,
2529-2535[Abstract/Free Full Text]
|
| 51.
|
Merino, S.,
Altarriba, M.,
Izquierdo, L.,
Nogueras, M. M.,
Regue, M.,
and Tomas, J. M.
(2000)
Infect. Immun.
68,
2435-2440[Abstract/Free Full Text]
|
| 52.
|
Preston, A.,
Allen, A. G.,
Cadisch, J.,
Thomas, R.,
Stevens, K.,
Churcher, C. M.,
Badcock, K. L.,
Parkhill, J.,
Barrell, B.,
and Maskell, D. J.
(1999)
Infect. Immun.
67,
3763-3767[Abstract/Free Full Text]
|
| 53.
|
Heinrichs, D. E.,
Yethon, J. A.,
Amor, P. A.,
and Whitfield, C.
(1998)
J. Biol. Chem.
273,
29497-29505[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
V. Kos, L. Cuthbertson, and C. Whitfield
The Klebsiella pneumoniae O2a Antigen Defines a Second Mechanism for O Antigen ATP-binding Cassette Transporters
J. Biol. Chem.,
January 30, 2009;
284(5):
2947 - 2956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lukasiewicz, T. Niedziela, W. Jachymek, L. Kenne, and C. Lugowski
Two Kdo-Heptose Regions Identified in Hafnia alvei 32 Lipopolysaccharide: the Complete Core Structure and Serological Screening of Different Hafnia O Serotypes
J. Bacteriol.,
January 15, 2009;
191(2):
533 - 544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Steiner, R. Novotny, D. B. Werz, K. Zarschler, P. H. Seeberger, A. Hofinger, P. Kosma, C. Schaffer, and P. Messner
Molecular Basis of S-layer Glycoprotein Glycan Biosynthesis in Geobacillus stearothermophilus
J. Biol. Chem.,
July 25, 2008;
283(30):
21120 - 21133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Cuthbertson, M. S. Kimber, and C. Whitfield
Substrate binding by a bacterial ABC transporter involved in polysaccharide export
PNAS,
December 4, 2007;
104(49):
19529 - 19534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fresno, N. Jimenez, L. Izquierdo, S. Merino, M. M. Corsaro, C. De Castro, M. Parrilli, T. Naldi, M. Regue, and J. M. Tomas
The ionic interaction of Klebsiella pneumoniae K2 capsule and core lipopolysaccharide
Microbiology,
June 1, 2006;
152(6):
1807 - 1818.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Regue, L. Izquierdo, S. Fresno, N. Jimenez, N. Pique, M. M. Corsaro, M. Parrilli, T. Naldi, S. Merino, and J. M. Tomas
The Incorporation of Glucosamine into Enterobacterial Core Lipopolysaccharide: TWO ENZYMATIC STEPS ARE REQUIRED
J. Biol. Chem.,
November 4, 2005;
280(44):
36648 - 36656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Cuthbertson, J. Powers, and C. Whitfield
The C-terminal Domain of the Nucleotide-binding Domain Protein Wzt Determines Substrate Specificity in the ATP-binding Cassette Transporter for the Lipopolysaccharide O-antigens in Escherichia coli Serotypes O8 and O9a
J. Biol. Chem.,
August 26, 2005;
280(34):
30310 - 30319.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Frirdich, C. Bouwman, E. Vinogradov, and C. Whitfield
The Role of Galacturonic Acid in Outer Membrane Stability in Klebsiella pneumoniae
J. Biol. Chem.,
July 29, 2005;
280(30):
27604 - 27612.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Frirdich and C. Whitfield
Characterization of GlaKP, a UDP-Galacturonic Acid C4-Epimerase from Klebsiella pneumoniae with Extended Substrate Specificity
J. Bacteriol.,
June 15, 2005;
187(12):
4104 - 4115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Regue, L. Izquierdo, S. Fresno, N. Pique, M. M. Corsaro, T. Naldi, C. De Castro, D. Waidelich, S. Merino, and J. M. Tomas
A Second Outer-Core Region in Klebsiella pneumoniae Lipopolysaccharide
J. Bacteriol.,
June 15, 2005;
187(12):
4198 - 4206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Frirdich and C. Whitfield
Review: Lipopolysaccharide inner core oligosaccharide structure and outer membrane stability in human pathogens belonging to the Enterobacteriaceae
Innate Immunity,
June 1, 2005;
11(3):
133 - 144.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kahlig, D. Kolarich, S. Zayni, A. Scheberl, P. Kosma, C. Schaffer, and P. Messner
N-Acetylmuramic Acid as Capping Element of {alpha}-D-Fucose-containing S-layer Glycoprotein Glycans from Geobacillus tepidamans GS5-97T
J. Biol. Chem.,
May 27, 2005;
280(21):
20292 - 20299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Clarke, L. Cuthbertson, and C. Whitfield
Nonreducing Terminal Modifications Determine the Chain Length of Polymannose O Antigens of Escherichia coli and Couple Chain Termination to Polymer Export via an ATP-binding Cassette Transporter
J. Biol. Chem.,
August 20, 2004;
279(34):
35709 - 35718.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Feng, S. N. Senchenkova, J. Yang, A. S. Shashkov, J. Tao, H. Guo, J. Cheng, Y. Ren, Y. A. Knirel, P. R. Reeves, et al.
Synthesis of the Heteropolysaccharide O Antigen of Escherichia coli O52 Requires an ABC Transporter: Structural and Genetic Evidence
J. Bacteriol.,
July 15, 2004;
186(14):
4510 - 4519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Frirdich, E. Vinogradov, and C. Whitfield
Biosynthesis of a Novel 3-Deoxy-D-manno-oct-2-ulosonic Acid-containing Outer Core Oligosaccharide in the Lipopolysaccharide of Klebsiella pneumoniae
J. Biol. Chem.,
July 2, 2004;
279(27):
27928 - 27940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Shankar-Sinha, G. A. Valencia, B. K. Janes, J. K. Rosenberg, C. Whitfield, R. A. Bender, T. J. Standiford, and J. G. Younger
The Klebsiella pneumoniae O Antigen Contributes to Bacteremia and Lethality during Murine Pneumonia
Infect. Immun.,
March 1, 2004;
72(3):
1423 - 1430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Regue, B. Hita, N. Pique, L. Izquierdo, S. Merino, S. Fresno, V. J. Benedi, and J. M. Tomas
A Gene, uge, Is Essential for Klebsiella pneumoniae Virulence
Infect. Immun.,
January 1, 2004;
72(1):
54 - 61.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Izquierdo, S. Merino, M. Regue, F. Rodriguez, and J. M. Tomas
Synthesis of a Klebsiella pneumoniae O-Antigen Heteropolysaccharide (O12) Requires an ABC 2 Transporter
J. Bacteriol.,
March 1, 2003;
185(5):
1634 - 1641.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|